Search Results
Results found for "Dr. Thomas P. Sakmar"
- đź“° GPCR Weekly News, January 29 to February 4, 2024
Preston Nibley, Dr. Sudha K Shenoy et al. Dr. Xavier Leroy for his new role as CEO of GIO Therapeutics Dr. Confirmed speakers include Drs. Dr. Dr.
- đź“° GPCR Weekly News, February 5 to 11, 2024
This week's highlight includes congrats to: Drs. Confirmed speakers include Drs. Dr. Dr. Dr. GPCR Members get 10% off with code MPDRGPCR10.
- Quantifying Receptor Selectivity in Modern Drug Discovery
But as Dr. In the full lecture, Dr. Dr. Kenakin uses a lever analogy where: Efficacy is the weight applied. Dr. Why Terry’s Corner Terry’s Pharmacology Corner delivers weekly lectures from Dr.
- Microbial Metabolites Orchestrate a Distinct Multi-Tiered Regulatory Network in the Intestinal Epith
Expression "P-glycoprotein (P-gp) is a key component of the intestinal epithelium playing a pivotal secondary bile acids, produced by the intestinal microbiome, potentiate the induction of functional P-gp We now aim to determine the molecular mechanism by which this functional microbiome output regulates P-gp combination discovered a unique transcriptional program involving multiple pathways that converge on P-gp on a sophisticated signaling network directed by intestinal microbial metabolites that orchestrate P-gp
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Popov, P.; Benchama, O.; Zvonok, N.; Locke, K.; Qu, L.; Han, G. W.; Iyer, M. V.; Van Der Stelt, M.; Pacher, P.; Gertsch, J.; Ullmer, C.; McCormick, P. J.; Oddi, S.; Spaink, H. P.; Maccarrone, M.; Veprintsev, D. B.; Carreira, E. M.; Grether, U.; Nazaré, M. -P. -F.; Farce, A.; Chavatte, P.; Poupaert, J. H.; Lambert, D. M.; Depreux, P.; Hénichart, J.-P.
- đź“° GPCR Weekly News, March 11 to 17, 2024
work on Direct interrogation of context-dependent GPCR activity with a universal biosensor platform Dr Dr. GPCR University Save the date for our upcoming workshop, starting May 9th, 2024, featuring Dr. Under Dr. Hoare's expert guidance, you will gain invaluable skills in data analysis. Dr. Terry Kenakin's "Applying Pharmacology to Drug Discovery" course at Dr. Dr.
- Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls
Dr. Kenakin is unequivocal: do not use them. Dr. Experimental Conditions That Make or Break Orthosteric Binding Data Dr. Dr. Why Terry’s Corner Weekly pharmacology sessions with Dr.
- Pharmacology at Your Fingertips: Terry’s Corner Launches
Explore 10 on-demand lessons by Dr. Visit Yamina’s Corner Now CELT-335 - Celtarys Validates New Assay for CB1/CB2 Screening Dr. Stay curious,  The Dr. GPCR Team Join Our Newsletter!
- đź“° GPCR Weekly News, December 4 to 10, 2023
This week's highlight: Dr. GPCR University live Zoom sessions hosted by Dr. Terry Kenakin. Registrations open on December 15th and close on February 1st to both Dr. The package includes four live Zoom sessions, a one-year Dr. Kenakin and Dr. GPCR.
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
phosphorylation of the G protein subunit Gαi at specific residues within three strategic hotspots: the P Key findings include: Phosphorylation Hotspots: P Loop (Ser44, Ser47, Thr48): Impairs ligand-stimulated Signaling Pathway Segregation: Phosphorylation events in the interdomain cleft and P loop uncouple G J., Ghassemian, M., Kufareva, I., & Ghosh, P. (2024).
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
Welcome to this week’s Dr. multiple transducers; plus obesity-drug program milestones and company pipeline updates. 🔍 This Week in Dr stay ahead of the science 🧠Content built for biotech, pharma & academia 💬 Live monthly AMA with Dr Kenakin   💎 $2999/year — one conference cost = 12 months of expert training  Premium Dr. For Dr.
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
That’s the mission of Dr. Dr. . 🎧 Listen to the full episode of the Dr. GPCR Podcast Push the boundaries of what's possible 👉 Join the Dr.
- đź“° GPCR Weekly News, July 31 to August 6, 2023
This week's highlights: Dr. Randy Hall's study: GPR37L1's role in shaping cortical astrocytes during development Dr. The Dr. GPCR Symposium on 'GPCRs as Therapeutic Modalities' is set for September 22nd. Stay updated with the Dr. GPCR Newsletter for confirmed speaker announcements. Robert Lefkowitz Lab Postdoc Fellow - Dr.
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
Hello Dr. GPCR ecosystem members! also the hiring manager for their open Principal Scientist, In Vitro Pharmacology role posted in the Dr By: Mark Schmeizl Chief Matchmaker at Dr. GPCR
- Regulators of G-protein signaling: essential players in GPCR signaling
Cell, 1997. 89(2): p. 251-61. https://pubmed.ncbi.nlm.nih.gov/9108480/ 2. Front Mol Neurosci, 2020. 13: p. 5. https://pubmed.ncbi.nlm.nih.gov/32038168/ 3. Cell, 2021. 184(4): p. 931-942.e18. https://pubmed.ncbi.nlm.nih.gov/33571431/ 6. J Neurosci, 2019. 39(42): p. 8291-8304. https://pubmed.ncbi.nlm.nih.gov/31308097/ 8. Genomics, 2021. 113(4): p. 2134-2144. https://pubmed.ncbi.nlm.nih.gov/33845140/
- đź“° GPCR Weekly News, July 17 to July 23, 2023
This week's highlighted papers: Dr. Dr. Mark your calendars for the upcoming Dr. Stay updated by subscribing to Dr. GPCR Newsletter! Robert Lefkowitz Lab NEW Postdoc Fellow - Dr.
- đź“° GPCR Weekly News, July 24 to July 30, 2023
Dr. Drs. Stay tuned by subscribing to the Dr. GPCR Newsletter! In case you missed it, recordings of the Dr. Robert Lefkowitz Lab Postdoc Fellow - Dr.
- Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs)...
clinical parameters such as alpha-fetoprotein and tumor grade in the HCC patients; (c) besides HCC (p was found to be an important factor for survival in four other cancers (clear renal cell carcinoma: p < 0.001, lung adenocarcinoma: p = 0.004, mesothelioma: p = 0.039, ovarian serous cystadenocarcinoma: p = 0.048); (d) RGS20 was found to be significantly associated with some tumor-related signaling pathways
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
In the full lecture, Dr. Linearity  of the Schild regression (log(DR–1) vs. antagonist concentration). As Dr. Watch the course trailer 👇 Why Terry’s Corner Weekly pharmacology lectures by Dr.
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
🎥 Coming Soon: Live AMA with Dr. Terry Kenakin This Month’s Live AMA — October 30 at 12 PM EST Join Dr. course topics Weekly new releases  — always fresh, always relevant Live monthly AMA  sessions with Dr , pharma, and academia 💎 $2999/year — one conference cost = a full year of expert training Premium Dr Monthly AMAs  where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.
- đź“° Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
This week's highlight: Dr. November Dr. GPCR Newsletter is out now. Subscribe for this month's video featuring Dr. Ensure to catch the upcoming episodes of Dr. GPCR Podcast featuring Dr. Neil Grimsey and Dr. Researcher Post-Doctoral Fellow Sr Scientist in Obesity, Muscle, and Metabolism Post-Doctoral Fellow Explore Dr
- Pharmacologic Models
Ecosystem Premium Members: Look for significant savings on this and other resources in your weekly Dr
- đź“° GPCR Weekly News, November 20 to 26, 2023
This week's highlight: Thank you to Dr. Molecular Sensing in Adhesion GPCR Dissociation Physiological Force Modulation in Drosophila Neurons Dr Our November Dr. GPCR Newsletter is now available. This month's video newsletter features Dr. Don't miss the upcoming episodes of Dr.GPCR Podcast featuring Dr. Neil Grimsey and Dr. Fellow Research Associate I, Tissue Culture Post-Doc Research Associate Postdoctoral Fellow Explore Dr
- đź“° GPCR Weekly News, March 18 to 24, 2024
This week's highlight includes congrats to: Drs. Dr. GPCR Symposia With a premium membership, you can watch on-demand the Dr. Dr. Behavior Director of Laboratory Operations - Single-molecule Imaging Center Scientific Assistant Join Dr
- đź“° GPCR Weekly News, September 4 to 10, 2023
This week's highlights: Dr. Yamina Berchiche, Founder and Director of Dr. Dr. Dr. Save these dates: September 22: Join us for the Dr. Subscribe to the Dr. GPCR Newsletter for more insights!
- Exploring the Breakthroughs in GPCR Research
This week's highlight includes congrats to: Remi Janicot, and Dr. on the Relevance of GPCR dynamics for receptor activation, signalling bias and allosteric modulation Drs study on the Role of the V2R-βarrestin-Gβγ complex in promoting G protein translocation to endosomes Dr GPCR University We are excited to announce the dates for our upcoming courses led by Dr. Director GPCR Drug Discovery Biologist Post-Doctoral Scientist- Molecular Pharmacology (FDE) Join Dr.
- High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and...
of patients showed high GPER expression and significant correlation with the mRNA subtype of TNBC (P  = 0.001), total metastatic events (P = 0.019) and liver metastasis (P = 0.011). interval of 67.1 months, a significant trend towards reduced distant metastasis-free survival (DMFS) (P 
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
🎥 Next Week's Release: The First AMA Session The first Ask-Me-Anything with Dr. course topics Weekly new releases  — always fresh, always relevant Live monthly AMA  sessions with Dr , pharma, and academia 💎 $2999/year — one conference cost = a full year of expert training Premium Dr Monthly AMAs  where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
This week in Terry’s Corner, Dr. DR curves shift to the right with no loss of maximal effect. Each subscription includes: Weekly deep dives from Dr.













